Literature DB >> 30426787

Assessment of the 8th edition of TNM staging system for gastric cancer: the results from the SEER and a single-institution database.

Bochao Zhao1, Jingting Zhang1, Jiale Zhang1, Rui Luo1, Zhenning Wang1, Huimian Xu1, Baojun Huang1.   

Abstract

AIM: To investigate whether the 8th edition of Tumor, Node, Metastasis (TNM) staging could properly evaluate the prognosis of gastric cancer patients.
METHODS: The prognostic performance between the 7th and 8th edition of TNM staging was compared and clinicopathologic features were analyzed.
RESULTS: The stage shifts in the 8th edition staging resulted in the increased numbers of stage IIIA patients and decreased numbers of stage IIB, stage IIIB and stage IIIC patients. Compared with the previous edition, the 8th edition of TNM staging provided a better prognostic stratification for stage III patients. However, whether it is reasonable to incorporate T4aN2, T4aN3a and T4bN3b into stage IIIA, stage IIIB and stage IIIC respectively, which still need further validation.
CONCLUSION: Despite the obvious superiority, several deficiencies may still exist in the new edition staging. To better provide prognostic information and therapeutic guidance for gastric cancer patients, the TNM staging system should be further improved in the future.

Entities:  

Keywords:  TNM staging; gastric cancer; prognosis

Mesh:

Year:  2018        PMID: 30426787     DOI: 10.2217/fon-2018-0299

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  6 in total

1.  The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9.

Authors:  Shun Zhang; Jing-Ze Li; Tao Du; Hai-Qiang Li; Ren-Hao Hu; Chi-Ye Ma; Xi-Mao Cui; Chun Song; Xiao-Hua Jiang
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-13

2.  A validated survival nomogram for early-onset diffuse gastric cancer.

Authors:  Fei Liao; Xufeng Guo; Xiaohong Lu; Weiguo Dong
Journal:  Aging (Albany NY)       Date:  2020-07-08       Impact factor: 5.682

3.  Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component.

Authors:  Ziyu Zhu; Xiliang Cong; Rui Li; Xin Yin; Chunfeng Li; Yingwei Xue
Journal:  Biomed Res Int       Date:  2020-05-22       Impact factor: 3.411

4.  Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Bone Metastasis: A SEER-Based Study.

Authors:  Chen Xiaobin; Xu Zhaojun; Liu Tao; Dai Tianzeng; Huang Xuemei; Zheng Fan; Huang Chunyin; Huang Jianqiang; Lin Chen
Journal:  J Immunol Res       Date:  2022-02-15       Impact factor: 4.818

5.  Multivariate analysis of clinicopathological and prognostic significance of miRNA 106b~25 cluster in gastric cancer.

Authors:  Fangxuan Li; Jinchao Huang; Juntian Liu; Wengui Xu; Zhiyong Yuan
Journal:  Cancer Cell Int       Date:  2019-07-29       Impact factor: 5.722

6.  Long noncoding RNA CCAT1 rs67085638 SNP contribution to the progression of gastric cancer in a Polish population.

Authors:  Tomasz Olesiński; Anna Lutkowska; Adam Balcerek; Anna Sowińska; P Piotrowski; Tomasz Trzeciak; Tomasz Maj; Piotr Hevelke; Pawel P Jagodziński
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.